Exposure of murine splenic B cells to insoluble anti-Ig for 48 h yields low density B cell blasts (anti-Ig blasts) that proliferate and secrete IgM when recultured with either LPS or T cell-derived lymphokines (1, 2). Culture of anti-Ig blasts with a mixture of T cell-derived lymphokines that includes IL-4 (EL4 Sn) (1, 2) results in secretion of IgGI, which is blocked by monoclonal anti-IL-4 (1) . Thus, IL-4 can alter Ig isotype expression in B cells pre-activated by anti-Ig . However, IL-4 alone does not sustain proliferation nor promote differentiation of anti-Ig blasts (1, 2), suggesting that other lymphokines are required to enable IL-4-induced IgGl secretion . We have examined the effects of other T cell-derived lymphokines on IL-4-mediated IgGI secretion . While IL-4 was capable of suppressing IgM secretion from LPSstimulated anti-Ig blasts, secretion of IgGI required lymphokines in addition to IL-4, including IL-5 and IL-2.
Brief Definitive Report
Mice . BALB/c mice were obtained from Cumberland Farms, Clinton, TN and used at 6-12 wk of age.
Reagents. Affinity-purified antibodies were obtained fromJackson Immunoresearch, Avondale, PA (goat anti-mouse IgM + IgG, and anti-w chain and anti-y chain), and from Southern Biotechnology Associates, Birmingham, AL (goat anti-IgGI, and goat anti-1c) . Myeloma standards were obtained from Litton Bionetics, Charleston, SC (MOPC 21) . Monoclonal rat anti-IL-4 (11B11) was generously provided by Dr. E. S. Vitetta (Southwestern Medical School, Dallas, TX). Radiochemicals were obtained from New England Nuclear, Boston, MA. Salmonella typhosa LPS was purchased from Difco Laboratories Inc., Detroit, MI.
T Cell Supernatants. Lymphokine-containing supernatant (Sn) was obtained from EL4 cells as previously described, except serum-free conditions were used (3) . IL-4-depleted Sn, [(D)EL4 Sn] was prepared by twice passing EL4 Sn over an anti-IL-4 affinity column (11B11-Sepharose, see below) .
Lymphokines. rIL-2 was provided by Dr. J. Farrar (Hoffman-LaRoche, Inc., Nutley, NJ) . rIL-5 was produced in Xenopus oocytes, as described (4), using a plasmid containing IL-5 cDNA provided by Dr. T. Honjo (Kyoto University, Kyoto, Japan). 1 U of IL-5 was defined as the amount of IL-5 required for 1/3 maximal stimulation of [3H]thymidine incorporation by BCLI cells. IL-4 was affinity purified from EL-4 Sn using a 11B11-Sepharose column as described by Ohara et al. B CellPreparations. B cells were prepared by treating spleen cells with antiThy-1 and L3T4 followed by lysis with baby rabbit serum (Pel-Freeze Biologicals, Rogers, AR) . In some experiments splenic B cells were isolated by panning on anti-Ig-coated plates . High density B cells (1.081-1.086 g/ml) were isolated on discontinuous Percoll density gradients as described (2) .
Cell Culture. Anti-Ig blasts were prepared from high density or unfractioned splenic B cells isolated by centrifugation (400g for 10 min) over Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) as described (1, 2) . Blasts were washed and recultured (in RPMI 1640, 5% FCS, 5 gg/ml gentamicin, and 50 pM 2-ME) at 2 x 104 cells/0 .2 ml with 20 pg/ml LPS in 96-well microtiter plates . All additions were made in triplicate .
RIA . Culture supernatant was assayed for Ig isotypes by solid-phase RIA (1).
Results
Lymphokine Dependence of IL-4-mediated IgG1 Secretionfrom Anti-Ig Blasts. IL-4 stimulates secretion of IgG1 from resting B cells in the presence of LPS (6-9), and from anti-Ig blasts in concert with other lymphokines (1) . We first asked whether LPS and affinity-purified IL-4 were sufficient to elicit IgG1 secretion from anti-Ig blasts. In contrast to results with resting B cells, culture of anti-Ig blasts with LPS and IL-4 at concentrations up to 50 U/ml had virtually no effect on IgG1 secretion ( (Fig. 3 B) . 
